Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (AMPoL)
Effect of Antiseptic Mouthwash/Gargling Solutions and Pre-procedural Rinse on SARS-CoV-2 Load (COVID-19)
Sponsor: Rowpar Pharmaceuticals, Inc.
Terminated
The funder decided not to continue funding, causing enrollment to cease prematurely and curtailing originally planned analyses. Participants with any samples collected after the baseline pre-rinse samples were included in the analysis.
Listed as NCT04409873, this PHASE2 trial focuses on COVID-19 and Coronavirus Infections and remains terminated or withdrawn. Sponsored by Rowpar Pharmaceuticals, Inc., it has been updated 14 times since 2021, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Oct 2022 — Dec 2023 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Jun 2022 — Oct 2022 [monthly]
Recruiting PHASE2
▶ Show 9 earlier versions
-
Nov 2021 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jun 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Rowpar Pharmaceuticals, Inc.
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .